The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Neuromodulation Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neuromodulation Devices in various end use industries. The expanding demands from the Pain Management, Parkinson’s Disease, Urinary and Fecal Incontinence and Epilepsy, are propelling Neuromodulation Devices market. Deep Brain Stimulation (DBS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spinal Cord Stimulation (SCS) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuromodulation Devices market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuromodulation Devices market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuromodulation Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuromodulation Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuromodulation Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuromodulation Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuromodulation Devices covered in this report include Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, NeuroPace, Beijing Pins and Synapse Biomedical, etc.
The global Neuromodulation Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- Nevro
- NeuroPace
- Beijing Pins
- Synapse Biomedical
Global Neuromodulation Devices market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuromodulation Devices market, Segment by Type:
- Deep Brain Stimulation (DBS)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
Global Neuromodulation Devices market, by Application:
- Pain Management
- Parkinson’s Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Neuromodulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Neuromodulation Devices Market Overview
1.1 Neuromodulation Devices Product Overview
1.2 Neuromodulation Devices Market Segment by Type
1.2.1 Deep Brain Stimulation (DBS)
1.2.2 Spinal Cord Stimulation (SCS)
1.2.3 Vagus Nerve Stimulation (VNS)
1.2.4 Sacral Nerve Stimulation (SNS)
1.2.5 Gastric Electrical Stimulation (GES)
1.3 Global Neuromodulation Devices Market Size by Type
1.3.1 Global Neuromodulation Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Neuromodulation Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Neuromodulation Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neuromodulation Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Neuromodulation Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Neuromodulation Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Neuromodulation Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Neuromodulation Devices Sales Breakdown by Type (2018-2023)
2 Global Neuromodulation Devices Market Competition by Company
2.1 Global Top Players by Neuromodulation Devices Sales (2018-2023)
2.2 Global Top Players by Neuromodulation Devices Revenue (2018-2023)
2.3 Global Top Players by Neuromodulation Devices Price (2018-2023)
2.4 Global Top Manufacturers Neuromodulation Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neuromodulation Devices Market Competitive Situation and Trends
2.5.1 Neuromodulation Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Neuromodulation Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Neuromodulation Devices Market
2.8 Key Manufacturers Neuromodulation Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neuromodulation Devices Status and Outlook by Region
3.1 Global Neuromodulation Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Neuromodulation Devices Historic Market Size by Region
3.2.1 Global Neuromodulation Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Neuromodulation Devices Sales in Value by Region (2018-2023)
3.2.3 Global Neuromodulation Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Neuromodulation Devices Forecasted Market Size by Region
3.3.1 Global Neuromodulation Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Neuromodulation Devices Sales in Value by Region (2024-2029)
3.3.3 Global Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Neuromodulation Devices by Application
4.1 Neuromodulation Devices Market Segment by Application
4.1.1 Pain Management
4.1.2 Parkinson’s Disease
4.1.3 Urinary and Fecal Incontinence
4.1.4 Epilepsy
4.1.5 Gastroparesis
4.1.6 Other
4.2 Global Neuromodulation Devices Market Size by Application
4.2.1 Global Neuromodulation Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Neuromodulation Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Neuromodulation Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neuromodulation Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Neuromodulation Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Neuromodulation Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Neuromodulation Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Neuromodulation Devices Sales Breakdown by Application (2018-2023)
5 North America Neuromodulation Devices by Country
5.1 North America Neuromodulation Devices Historic Market Size by Country
5.1.1 North America Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Neuromodulation Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Neuromodulation Devices Sales in Value by Country (2018-2023)
5.2 North America Neuromodulation Devices Forecasted Market Size by Country
5.2.1 North America Neuromodulation Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Neuromodulation Devices Sales in Value by Country (2024-2029)
6 Europe Neuromodulation Devices by Country
6.1 Europe Neuromodulation Devices Historic Market Size by Country
6.1.1 Europe Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Neuromodulation Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Neuromodulation Devices Sales in Value by Country (2018-2023)
6.2 Europe Neuromodulation Devices Forecasted Market Size by Country
6.2.1 Europe Neuromodulation Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Neuromodulation Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Neuromodulation Devices by Region
7.1 Asia-Pacific Neuromodulation Devices Historic Market Size by Region
7.1.1 Asia-Pacific Neuromodulation Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Neuromodulation Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Neuromodulation Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Neuromodulation Devices Sales in Value by Region (2024-2029)
8 Latin America Neuromodulation Devices by Country
8.1 Latin America Neuromodulation Devices Historic Market Size by Country
8.1.1 Latin America Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Neuromodulation Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Neuromodulation Devices Sales in Value by Country (2018-2023)
8.2 Latin America Neuromodulation Devices Forecasted Market Size by Country
8.2.1 Latin America Neuromodulation Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Neuromodulation Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Neuromodulation Devices by Country
9.1 Middle East and Africa Neuromodulation Devices Historic Market Size by Country
9.1.1 Middle East and Africa Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Neuromodulation Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Neuromodulation Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Neuromodulation Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Neuromodulation Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Neuromodulation Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Neuromodulation Devices Products Offered
10.1.5 Medtronic Recent Development
10.2 Boston Scientific
10.2.1 Boston Scientific Company Information
10.2.2 Boston Scientific Introduction and Business Overview
10.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boston Scientific Neuromodulation Devices Products Offered
10.2.5 Boston Scientific Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Neuromodulation Devices Products Offered
10.3.5 Abbott Recent Development
10.4 LivaNova
10.4.1 LivaNova Company Information
10.4.2 LivaNova Introduction and Business Overview
10.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LivaNova Neuromodulation Devices Products Offered
10.4.5 LivaNova Recent Development
10.5 Nevro
10.5.1 Nevro Company Information
10.5.2 Nevro Introduction and Business Overview
10.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nevro Neuromodulation Devices Products Offered
10.5.5 Nevro Recent Development
10.6 NeuroPace
10.6.1 NeuroPace Company Information
10.6.2 NeuroPace Introduction and Business Overview
10.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NeuroPace Neuromodulation Devices Products Offered
10.6.5 NeuroPace Recent Development
10.7 Beijing Pins
10.7.1 Beijing Pins Company Information
10.7.2 Beijing Pins Introduction and Business Overview
10.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Beijing Pins Neuromodulation Devices Products Offered
10.7.5 Beijing Pins Recent Development
10.8 Synapse Biomedical
10.8.1 Synapse Biomedical Company Information
10.8.2 Synapse Biomedical Introduction and Business Overview
10.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Synapse Biomedical Neuromodulation Devices Products Offered
10.8.5 Synapse Biomedical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neuromodulation Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neuromodulation Devices Industrial Chain Analysis
11.4 Neuromodulation Devices Market Dynamics
11.4.1 Neuromodulation Devices Industry Trends
11.4.2 Neuromodulation Devices Market Drivers
11.4.3 Neuromodulation Devices Market Challenges
11.4.4 Neuromodulation Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neuromodulation Devices Distributors
12.3 Neuromodulation Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
